Your browser is no longer supported. Please, upgrade your browser.
Settings
IDXG Interpace Diagnostics Group, Inc. daily Stock Chart
IDXG [NASD]
Interpace Diagnostics Group, Inc.
Index- P/E- EPS (ttm)-0.52 Insider Own1.50% Shs Outstand38.13M Perf Week11.14%
Market Cap30.93M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float37.90M Perf Month6.69%
Income-16.60M PEG- EPS next Q-0.09 Inst Own18.90% Short Float3.78% Perf Quarter15.90%
Sales23.90M P/S1.29 EPS this Y42.80% Inst Trans-16.85% Short Ratio6.07 Perf Half Y-14.67%
Book/sh0.81 P/B1.00 EPS next Y65.90% ROA-31.00% Target Price3.22 Perf Year-44.05%
Cash/sh0.11 P/C7.37 EPS next 5Y15.00% ROE-46.40% 52W Range0.67 - 1.78 Perf YTD1.41%
Dividend- P/FCF- EPS past 5Y16.50% ROI-39.30% 52W High-54.42% Beta2.29
Dividend %- Quick Ratio1.70 Sales past 5Y-31.60% Gross Margin53.80% 52W Low20.60% ATR0.05
Employees89 Current Ratio1.70 Sales Q/Q14.50% Oper. Margin-64.90% RSI (14)63.22 Volatility6.69% 6.44%
OptionableNo Debt/Eq0.00 EPS Q/Q-106.70% Profit Margin-65.90% Rel Volume0.87 Prev Close0.77
ShortableYes LT Debt/Eq0.00 EarningsAug 13 BMO Payout- Avg Volume235.93K Price0.81
Recom1.80 SMA209.52% SMA503.91% SMA200-2.86% Volume204,987 Change5.36%
Feb-22-18Initiated Laidlaw Buy $4.50
Feb-14-18Reiterated Maxim Group Buy $5 → $3
Aug-15-17Initiated Maxim Group Buy $5
Sep-06-19 06:55AM  Interpace to Present at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright GlobeNewswire
Aug-20-19 05:44PM  Edited Transcript of IDXG earnings conference call or presentation 13-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-19-19 05:15PM  Predictive Oncology Inc. Reports Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-13-19 08:15AM  Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -10.86%
06:30AM  Interpace Diagnostics Group, Inc. to Host Earnings Call ACCESSWIRE
Aug-06-19 04:05PM  Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2019 Financial Results on Tuesday, August 13, 2019 GlobeNewswire
Jul-31-19 06:55AM  Interpace Diagnostics Announces Contract with Blue Cross Blue Shield of Michigan GlobeNewswire
Jul-29-19 06:55AM  Interpace Announces Contract with Blue Shield of California for ThyGeNEXT® & ThyraMIR® GlobeNewswire
Jul-22-19 06:55AM  Interpace Announces New Agreement with SelectHealth GlobeNewswire +8.84%
Jul-18-19 09:05AM  Interpace Diagnostics Partners With AI Specialist To Diagnose Thyroid Cancer Benzinga +6.25%
06:55AM  Interpace Diagnostics Enters Agreement with Predictive Oncology to Enhance Diagnosis of Thyroid Cancer Via AI-Driven Analysis GlobeNewswire
Jul-16-19 08:44AM  Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit Benzinga +16.60%
Jul-15-19 04:10PM  Interpace Diagnostics Acquires Cancer Genetics Biopharma Services Business Supported by Investment from Ampersand Capital Partners GlobeNewswire
11:04AM  Those Who Purchased Interpace Diagnostics Group (NASDAQ:IDXG) Shares Five Years Ago Have A 98% Loss To Show For It Simply Wall St.
Jun-20-19 06:55AM  Interpace Diagnostics Announces Coverage of Molecular Thyroid Testing by Independence Blue Cross GlobeNewswire +12.57%
Jun-13-19 06:55AM  Interpace Diagnostics Announces Presentation at the World Congress on Thyroid Cancer GlobeNewswire
May-27-19 05:06PM  Edited Transcript of IDXG earnings conference call or presentation 13-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-13-19 04:05PM  Interpace Diagnostics Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire -5.86%
May-09-19 06:55AM  Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week GlobeNewswire
May-06-19 06:55AM  Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results on Monday, May 13, 2019 GlobeNewswire
May-01-19 06:55AM  Interpace Diagnostics Announces Publication of Important New Data on Thyroid Test Performance GlobeNewswire
Apr-29-19 08:28AM  Interpace Diagnostics Group, Inc.'s (NASDAQ:IDXG) Shift From Loss To Profit Simply Wall St.
Apr-25-19 06:55AM  Interpace Diagnostics Labs Receive College of American Pathology (CAP) Accreditation GlobeNewswire
Apr-23-19 06:55AM  Interpace Diagnostics Announces New York State Approval GlobeNewswire +8.70%
Apr-02-19 06:55AM  Interpace Diagnostics Announces New Coverage of Thyroid Testing by Medica GlobeNewswire
Mar-21-19 06:48PM  Interpace Diagnostics Group Inc (IDXG) Files 10-K for the Fiscal Year Ended on December 31, 2018 GuruFocus.com
04:36PM  Edited Transcript of IDXG earnings conference call or presentation 19-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-19-19 04:05PM  Interpace Diagnostics Group Reports Full Year and Fourth Quarter 2018 Financial Results GlobeNewswire
Mar-07-19 01:46PM  What Kind Of Shareholder Owns Most Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) Stock? Simply Wall St.
Mar-04-19 06:55AM  Interpace Diagnostics Receives Regional Award as 2018 Top Life Sciences Company GlobeNewswire
Feb-28-19 06:55AM  Interpace Diagnostics Announces Preliminary 2018 Revenues GlobeNewswire
Feb-19-19 06:55AM  Interpace Diagnostics Announces First Independent Publication Demonstrating Clinical Utility of BarreGEN® GlobeNewswire
Feb-04-19 06:55AM  Interpace Diagnostics to Attend BIO CEO & Investor Conference in New York City GlobeNewswire
Jan-29-19 04:20PM  Interpace Diagnostics Announces Closing of $7.0 Million Public Offering of Common Stock GlobeNewswire
Jan-25-19 06:00AM  Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock GlobeNewswire -5.60%
Jan-24-19 04:35PM  Interpace Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
06:55AM  Interpace Diagnostics to Present at the Fifteenth Annual NobleCon GlobeNewswire
Jan-22-19 06:55AM  Interpace Diagnostics Announces Further Expansion of Thyroid Business GlobeNewswire
Jan-18-19 12:54PM  Is Interpace Diagnostics Group, Inc.s (NASDAQ:IDXG) CEO Paid Enough Relative To Peers? Simply Wall St.
Jan-14-19 06:55AM  Interpace Diagnostics Enters into Agreement with University of Maryland Medical System GlobeNewswire -6.92%
Dec-27-18 06:55AM  Interpace Diagnostics Ranked as Top 10 Bioinformatics Solutions Provider GlobeNewswire
Dec-21-18 10:39AM  Edited Transcript of IDXG earnings conference call or presentation 13-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-17-18 06:50AM  Interpace Announces Notice of Allowance from U.S. Patent and Trademark Office Covering BarreGEN® GlobeNewswire -5.85%
Dec-07-18 07:45AM  Detailed Research: Economic Perspectives on PayPal, Alphabet, Southern, Interpace Diagnostics Group, Edwards Lifesciences, and Laboratory Corporation of America What Drives Growth in Today's Competitive Landscape GlobeNewswire
Nov-28-18 06:55AM  Interpace Diagnostics Launches New Websites GlobeNewswire
Nov-27-18 09:48AM  Interpace Diagnostics Group Inc (NASDAQ:IDXG): Time For A Financial Health Check Simply Wall St.
Nov-26-18 06:55AM  Newly Published Data from National Study Supports Interpace Diagnostics PancraGEN® GlobeNewswire
Nov-13-18 04:17PM  Interpace Diagnostics Reports Third Quarter 2018 Financial Results, Business Progress and Recent Accomplishments GlobeNewswire
Nov-09-18 06:55AM  Interpace Diagnostics to Participate in 9th Annual Craig-Hallum Alpha Select Conference GlobeNewswire
Nov-07-18 08:06AM  Interpace Diagnostics Announces New Coverage by Blue Cross Blue Shield for Thyroid Testing GlobeNewswire
Nov-06-18 06:55AM  Interpace Diagnostics to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Tuesday, November 13, 2018 GlobeNewswire
Nov-05-18 10:30AM  Will Interpace Diagnostics (IDXG) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-30-18 08:45AM  Report: Exploring Fundamental Drivers Behind Century Aluminum, Insteel Industries, Altisource Portfolio Solutions S.A, Enova International, Stewart Information Services, and Interpace Diagnostics Group New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.56%
Oct-24-18 06:55AM  Interpace Diagnostics Announces Participation at the DJCON18 GlobeNewswire -8.45%
Oct-22-18 06:55AM  Interpace Diagnostics to Present at the 36th Annual Lab Institute 2018 GlobeNewswire
Oct-15-18 06:55AM  Interpace Diagnostics Presents Favorable New Data at the 88th Annual Meeting of the American Thyroid Association (ATA) GlobeNewswire
Oct-10-18 08:30AM  Interpace Diagnostics CEO Provides Corporate Update GlobeNewswire
Oct-04-18 06:55AM  Interpace Diagnostics Enters into Agreement with Renowned Integrated Health System GlobeNewswire
Oct-01-18 06:55AM  Interpace Diagnostics to Present New Data at the 88th Annual Meeting of the American Thyroid Association (ATA) on October 5th GlobeNewswire +9.09%
Sep-25-18 07:55AM  Report: Exploring Fundamental Drivers Behind Ocean Power Technologies, Amicus Therapeutics, Interpace Diagnostics Group, The Progressive, Fanhua, and Parsley Energy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Sep-24-18 06:55AM  Interpace Diagnostics Announces Reimbursement Expansion of ThyGeNEXT GlobeNewswire
Sep-18-18 11:56AM  What Kind Of Shareholders Own Interpace Diagnostics Group Inc (NASDAQ:IDXG)? Simply Wall St. +8.84%
Sep-17-18 08:30AM  Interpace Diagnostics Supports Research Efforts of Pancreatic and Thyroid Cancer Patient Advocacy Groups GlobeNewswire
Aug-31-18 02:44PM  Penny Stocks to Watch for September 2018 Investopedia
Aug-24-18 03:56PM  Edited Transcript of IDXG earnings conference call or presentation 9-Aug-18 8:30pm GMT Thomson Reuters StreetEvents +14.41%
Aug-20-18 04:30PM  Interpace Diagnostics to Present at the 10th Annual Next Generation Dx Summit 2018 GlobeNewswire
Aug-15-18 08:30AM  Interpace Diagnostics Acquires Select Assets of Rosetta Genomics Out of Bankruptcy GlobeNewswire
Aug-09-18 04:46PM  Interpace Diagnostics Group Reports Second Quarter 2018 Financial Results, Business Progress and Recent Accomplishments GlobeNewswire
02:30PM  Interpace Diagnostics Group, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 08:30AM  Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on Thursday, August 9, 2018 GlobeNewswire
Jul-31-18 08:30AM  Interpace Diagnostics Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement GlobeNewswire -6.36%
07:40AM  Report: Developing Opportunities within Amicus Therapeutics, Interpace Diagnostics Group, The Progressive, State Street, Alphabet, and VBI Vaccines Future Expectations, Projections Moving into 2018 GlobeNewswire
Jul-30-18 08:20AM  Report: Exploring Fundamental Drivers Behind Chemed, Sysco, Interpace Diagnostics Group, Navient, CenturyLink, and DENTSPLY SIRONA New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jul-26-18 08:37AM  Interpace Diagnostics Announces CIGNAs Expansion of Coverage to Now Include ThyraMIR® GlobeNewswire
Jul-19-18 08:30AM  Interpace Diagnostics Expands Application of Pancreatic Cancer Test GlobeNewswire
Jun-27-18 08:08AM  Should You Buy Interpace Diagnostics Group Inc (NASDAQ:IDXG) At US$00.8855? Simply Wall St.
Jun-11-18 08:00AM  Interpace Diagnostics Announces Coverage of Thyroid Testing by Blue Cross Blue Shield of Florida GlobeNewswire
Jun-08-18 07:10AM  Stock Performance Review on IHS Markit and Three Other Business Services Stocks ACCESSWIRE
Jun-04-18 08:30AM  Interpace Diagnostics to Attend and Present at the 8th Annual LD Micro Invitational Conference GlobeNewswire
Jun-01-18 08:30AM  Interpace Diagnostics Presents New Data on PancraGEN® at Digestive Disease Week GlobeNewswire
May-30-18 08:30AM  Interpace Diagnostics Enters into Agreement with Nationally Renowned Institution GlobeNewswire
May-23-18 04:03PM  Edited Transcript of IDXG earnings conference call or presentation 15-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-15-18 08:00AM  Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments GlobeNewswire -6.60%
May-14-18 08:30AM  Interpace Diagnostics Announces Launch of New Thyroid Test GlobeNewswire
May-11-18 09:10AM  Interpace Diagnostics to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments on Tuesday, May 15, 2018 GlobeNewswire
May-10-18 09:00AM  Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans GlobeNewswire
Apr-18-18 08:30AM  Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US GlobeNewswire
Apr-16-18 08:25AM  Detailed Research: Economic Perspectives on AmerisourceBergen, Builders FirstSource, Twilio, Gannett Co., Intel, and Interpace Diagnostics Group What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-02-18 08:30AM  Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California GlobeNewswire
07:20AM  Free Research Report as Verisks Quarterly Revenue Jumped 12.7%; Adjusted EPS Soared 67.5% ACCESSWIRE
Mar-28-18 08:30AM  Interpace Diagnostics Announces Agreement with Acupath Laboratories GlobeNewswire
Mar-23-18 10:10AM  LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm Zacks -5.52%
Mar-20-18 08:00AM  Interpace Diagnostics Announces Expansion of LabCorp National Agreement GlobeNewswire
Mar-16-18 01:20PM  Edited Transcript of IDXG earnings conference call or presentation 15-Mar-18 8:30pm GMT Thomson Reuters StreetEvents
Mar-15-18 04:01PM  Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments GlobeNewswire
Mar-14-18 02:30PM  Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call GlobeNewswire
Mar-09-18 07:45AM  New Research Coverage Highlights Great Western, Acadia Realty Trust, Interpace Diagnostics Group, Abercrombie & Fitch, United Rentals, and ZIOPHARM Oncology Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Mar-08-18 08:00AM  Interpace Diagnostics Announces Additional Coverage of Thyroid Tests GlobeNewswire
Feb-26-18 08:30AM  Horizon Blue Cross Blue Shield of New Jersey to Cover Interpaces Molecular Thyroid Tests GlobeNewswire
Feb-22-18 01:00PM  Interpace Diagnostics CEO Interviewed on The RedChip Money Report GlobeNewswire +12.47%
Interpace Diagnostics Group, Inc. develops and commercializes molecular diagnostic tests to detect genetic alterations associated with gastrointestinal, endocrine, and lung cancers. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that helps physicians better assess risk of pancreaticobiliary cancers using its proprietary PathFinderTG platform; ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules; ThyraMIR, an microRNA gene expression assay that helps to classify risk of cancer in thyroid nodules; and RespriDx, a genomic test to differentiate metastatic or recurrent lung cancer. The company also provides pathology services. It primarily serves physicians, hospitals, and clinics. The company was formerly known as PDI, Inc. and changed its name to Interpace Diagnostics Group, Inc. in December 2015. Interpace Diagnostics Group, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.